Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Kaluga Sales Company reported for 6 months of 2023 by IFRS

8/29/23 KLSB

Mechel reported for 6 months of 2023 by IFRS

8/29/23 MTLR

MMK reported for 6 months of 2023 by IFRS

8/29/23 MAGN

MKB reported for 6 months of 2023 by IFRS

8/29/23 CBOM

RusHydro reported for 6 months of 2023 by IFRS

8/29/23 HYDR

TNS Energo Voronezh reported for 6 months of 2023 by IFRS

8/29/23 VRSB

Buryatzoloto reported for 6 months of 2023 by IFRS

8/29/23 BRZL

ZIL reported for 6 months of 2023 by IFRS

8/29/23 ZILL

KGC reported for 6 months of 2023 by RAS

8/29/23 KGKC

"Mechel summarized its results in the first half of the year

8/29/23 MTLR